Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biologics
Pharma
AZ tacks on $2B to its investment in US manufacturing, R&D
Citing a rosy view of the U.S. economy’s potential for growth, AstraZeneca is boosting its investment in local manufacturing and R&D by $2 billion.
Fraiser Kansteiner
Nov 12, 2024 10:10am
Biologics gaining ground in HS, but more support needed: Spherix
Nov 11, 2024 11:52am
CDMO Avid to go private in $1.1B deal
Nov 7, 2024 2:50pm
CDMO Recipharm taps Exela to boost manufacturing services
Oct 2, 2024 9:37am
BeiGene CEO eyes biologics deals for new US hub
Jul 24, 2024 11:40am
UPDATED: J&J readies Tremfya for IBD showdown with AbbVie, Lilly
May 21, 2024 9:49am
